Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
InterMune Inc (NASDAQ:ITMN) 25 0 0
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) 6 3 2
TESARO Inc (NASDAQ:TSRO) 12 1 0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) 10 1 4
EXACT Sciences Corporation (NASDAQ:EXAS) 12 0 0

With the results shown by the aforementioned strategies, retail investors should always monitor hedge fund and insider trading activity, and Halozyme Therapeutics, Inc. (NASDAQ:HALO) shareholders fit into this picture quite nicely.

Click here to learn why you should track hedge funds

Page 2 of 2